---------------------------------------------------------------
详细处方信息以本药内容附件PDF文件（201931819330325.pdf）的“原文Priscribing Information”为准
---------------------------------------------------------------
部分中文FORTZAAR处方资料（仅供参考）

【英文名称】FORTZAAR

【禁忌】

FORTZAAR禁忌：

- 对本产品的任何成分过敏的患者

- 对其他磺胺衍生药物过敏的患者

- 患有无尿症的患者。

【适用证】

对AII受体拮抗剂或利尿剂作为单一疗法治疗反应不足的原发性高血压患者的治疗

【用法用量】

FORTZAAR可在餐前，餐中和餐后服用。

通常的起始和维持剂量是每天一次的一片HYZAAR（卡洛哌嗪/氢氯噻嗪50 / 12.5）。 如有必要，每天可将剂量增加至一片FORTZAAR。 如果患者在使用利尿剂单药治疗后接受卡乐菌素/氢氯噻嗪治疗，应在开始服用卡洛沙坦/氢氯噻嗪前2-3天停用利尿剂治疗。 老年患者不需要初始剂量调整。

【Therapeutic indications】

Treatment of patients with essential hypertension who have responded insufficiently to treatment with an AII receptor antagonist or a diuretic as monotherapy..

【Posology and method of administration】

FORTZAAR can be taken before, during and after meals.

The usual starting and maintenance dose is one tablet HYZAAR (kaliumlosartan/hydrochlorothiazide 50/12.5) once daily. If necessary, the dosage may be increased to one tablet FORTZAAR daily. If patients will be treated with kaliumlosartan/hydrochlorothiazide following monotherapy with a diuretic, the diuretic therapy should be stopped 2-3 days before kaliumlosartan/hydrochlorothiazide is started. No initial dosage adjustment is necessary for elderly patients.

【Contra-indications】

FORTZAAR is contraindicated in:

- Patients who are hypersensitive to any component of this product

- Patients who are hypersensitive to other sulfonamide-derived drugs

-Patients with anuria.

---------------------------------------------------------------
详细处方信息以本药内容附件PDF文件（201931819330325.pdf）的“原文Priscribing Information”为准
---------------------------------------------------------------